Literature DB >> 18333220

Evaluation of an online navigation system for laparoscopic interventions in a perfused ex vivo artificial tumor model of the liver.

Philipp Hildebrand1, Volker Martens, Achim Schweikard, Stefan Schlichting, Armin Besirevic, Markus Kleemann, Uwe Roblick, Lutz Mirow, C Bürk, Hans-Peter Bruch.   

Abstract

BACKGROUND: Laparoscopic radiofrequency ablation (RFA) is a safe and effective method for tumor destruction in patients with unresectable liver tumors. However, accurate probe placement using laparoscopic ultrasound guidance is required to achieve complete tumor ablation. After evaluation of an ultrasound navigation system for transcutaneous and open RFA, we now intend to transfer this technique to laparoscopic liver surgery. This study aimed to evaluate an electromagnetic navigation system for laparoscopic interventions using a perfusable ex vivo artificial tumor model.
MATERIALS AND METHODS: First a special adapter was developed to attach the ultrasound and electromagnetic tracking-based navigation system to a laparoscopic ultrasound probe. The laparoscopic online navigation system was studied in a laparoscopic artificial tumor model using perfused porcine livers. Artificial tumors were created by injection of a mixture of 3% agarose, 3% cellulose, and 7% glycerol, creating hyperechoic lesions in ultrasound.
RESULTS: This study showed that laparoscopic ultrasound-guided navigation is technically feasible. Even in cases of angulation of the ultrasound probe no disturbances of the navigation system could be detected. Artificial tumors were clearly visible on laparoscopic ultrasound and not felt during placement of the RFA probe. Anatomic landmarks and simulated 'tumors' in the liver could be reached safely. DISCUSSION: Laparoscopic RFA requires advanced laparoscopic ultrasound skills for accurate placement of the RFA probe. The use of an ultrasound-based, laparoscopic online navigation system offers the possibility of out-of-plane needle placement and could increase the safety and accuracy of punctures. The perfused artificial tumor model presented a realistic model for the evaluation of this new technique.

Entities:  

Year:  2007        PMID: 18333220      PMCID: PMC2063599          DOI: 10.1080/13651820601089077

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  11 in total

1.  Accuracy and effectiveness of laparoscopic vs open hepatic radiofrequency ablation.

Authors:  D J Scott; W N Young; L M Watumull; G Lindberg; J B Fleming; J F Huth; R V Rege; D R Jeyarajah; D B Jones
Journal:  Surg Endosc       Date:  2001-02       Impact factor: 4.584

2.  Development of an in vivo tumor-mimic model for learning radiofrequency ablation.

Authors:  M D Scott DJ; W N Young; L M Watumull; G Lindberg; J B Fleming; R V Rege; R J Brown; D B Jones
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

Review 3.  [Pathohistological findings in liver metastases].

Authors:  H Bläker; W J Hofmann; D Theuer; H F Otto
Journal:  Radiologe       Date:  2001-01       Impact factor: 0.635

Review 4.  [Indications and outcome of liver metastases resection].

Authors:  T Lehnert; M Golling
Journal:  Radiologe       Date:  2001-01       Impact factor: 0.635

Review 5.  Complications of radiofrequency coagulation of liver tumours.

Authors:  S Mulier; P Mulier; Y Ni; Y Miao; B Dupas; G Marchal; I De Wever; L Michel
Journal:  Br J Surg       Date:  2002-10       Impact factor: 6.939

6.  Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.

Authors:  S A Curley; F Izzo; P Delrio; L M Ellis; J Granchi; P Vallone; F Fiore; S Pignata; B Daniele; F Cremona
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

7.  Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases.

Authors:  A E Siperstein; S J Rogers; P D Hansen; A Gitomirsky
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

8.  Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome.

Authors:  P Hildebrand; T Leibecke; M Kleemann; L Mirow; M Birth; H P Bruch; C Bürk
Journal:  Eur J Surg Oncol       Date:  2006-03-07       Impact factor: 4.424

9.  Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution.

Authors:  Ronnie T Poon; Kelvin K Ng; Chi Ming Lam; Victor Ai; Jimmy Yuen; Sheung Tat Fan; John Wong
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

10.  Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  R Santambrogio; M Podda; M Zuin; E Bertolini; S Bruno; G P Cornalba; M Costa; M Montorsi
Journal:  Surg Endosc       Date:  2003-06-17       Impact factor: 4.584

View more
  4 in total

1.  Laparoscopic ultrasound: a survey of its current and future use, requirements, and integration with navigation technology.

Authors:  Cecilie Våpenstad; Anna Rethy; Thomas Langø; Tormod Selbekk; Brynjulf Ystgaard; Toril A Nagelhus Hernes; Ronald Mårvik
Journal:  Surg Endosc       Date:  2010-06-05       Impact factor: 4.584

Review 2.  Navigated laparoscopic ultrasound in abdominal soft tissue surgery: technological overview and perspectives.

Authors:  Thomas Langø; Sinara Vijayan; Anna Rethy; Cecilie Våpenstad; Ole Vegard Solberg; Ronald Mårvik; Gjermund Johnsen; Toril N Hernes
Journal:  Int J Comput Assist Radiol Surg       Date:  2011-09-03       Impact factor: 2.924

Review 3.  Interventional navigation systems for treatment of unresectable liver tumor.

Authors:  Soo Jay Phee; Kai Yang
Journal:  Med Biol Eng Comput       Date:  2009-12-30       Impact factor: 2.602

4.  Design and development of adapters for electromagnetic trackers to perform navigated laparoscopic radiofrequency ablation.

Authors:  Philipp Hildebrand; Armin Besirevic; Markus Kleemann; Stefan Schlichting; Volker Martens; Achim Schweikard; Hans-Peter Bruch
Journal:  Ann Surg Innov Res       Date:  2007-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.